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Clinics and pathology 
Disease 
Chronic myeloproliferative syndrome. 
Phenotype / cell stem origin 
Pluripotent stem cell is involved. 
Epidemiology 
Annual incidence is less than 1/106; sex ratio 1M/; 
median age 50-60 years. 
Clinics 
Often revealed by haemorrhages or thrombosis; 
splenomegaly is found in 50% of cases; blood data: the 
disease is defined by a thrombocytosis > 600 X 109L; 
the platelet count is actually often > 1000 X 109L. 
Prognosis 
Evolution: chronic disease; can evolve towards 
polycytemia vera or myelofibrosis, seldom towards 
ANLL; prognosis: often fair, is variable according to 
age and depends on haemorrhages, thromboses, and 










A normal karyotype is found in 95% of cases; +9 is the 
only anomaly having been described in as far as 4 
cases! 
Genes involved and Proteins 
Note: genes involved are unkown. 
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